Sukumar Nagendran, M.D., is a distinguished medical professional who currently holds the position of President and Head of Research and Development at Taysha Gene Therapies, Inc. Dr. Nagendran's journey in the medical field is marked by his extensive experience and contributions to the pharmaceutical and biotechnology industries. He earned his medical degree from the University of California, San Francisco, and completed his residency in pediatrics at the same institution. His career trajectory includes significant roles at major companies such as Vertex Pharmaceuticals, where he served as Senior Vice President and Chief Medical Officer, and Alexion Pharmaceuticals, where he was instrumental in advancing treatments for rare diseases. At Taysha Gene Therapies, Dr. Nagendran leads the company's efforts to develop and deliver innovative gene therapies for monogenic diseases of the central nervous system. His leadership has been pivotal in steering the company towards its mission of transforming the lives of patients with severe genetic disorders. Under his guidance, Taysha has made significant strides in advancing its clinical pipeline, including the development of TSHA-102 for the treatment of Rett syndrome and TSHA-120 for giant axonal neuropathy. Dr. Nagendran's expertise in clinical development and his strategic vision have been crucial in positioning Taysha as a leader in the gene therapy space. In addition to his role at Taysha, Dr. Nagendran has a robust history of contributing to the broader scientific community. He has authored numerous publications and has been an active participant in various professional organizations dedicated to advancing medical research. His commitment to improving patient outcomes is evident in his work, which consistently focuses on translating scientific discoveries into effective therapies. Dr. Nagendran's leadership at Taysha Gene Therapies not only highlights his professional achievements but also underscores his dedication to making a meaningful impact in the field of genetic medicine.